Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NeoGenomics, Inc. - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NEO
Nasdaq
8081
www.neogenomics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NeoGenomics, Inc.
The Bull Case For NeoGenomics (NEO) Could Change Following RaDaR Assay Data and Technology Platform Advances
- Nov 10th, 2025 3:11 pm
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
- Nov 9th, 2025 9:45 pm
3 Volatile Stocks We Keep Off Our Radar
- Nov 6th, 2025 11:32 am
NeoGenomics to Participate in Upcoming Investor Conferences
- Nov 6th, 2025 5:05 am
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
- Nov 3rd, 2025 10:38 pm
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
- Nov 3rd, 2025 9:01 pm
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
- Oct 30th, 2025 10:51 am
NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth
- Oct 30th, 2025 7:17 am
NeoGenomics (NEO) Valuation: Is the Recent Rebound a True Turning Point?
- Oct 30th, 2025 6:14 am
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
- Oct 28th, 2025 11:33 pm
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript
- Oct 28th, 2025 2:08 pm
Why NeoGenomics (NEO) Stock Is Trading Up Today
- Oct 28th, 2025 10:11 am
NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates
- Oct 28th, 2025 6:15 am
NeoGenomics’s (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars
- Oct 28th, 2025 5:49 am
NeoGenomics: Q3 Earnings Snapshot
- Oct 28th, 2025 5:15 am
NeoGenomics Reports Third Quarter 2025 Results
- Oct 28th, 2025 5:05 am
How Investors Are Reacting To NeoGenomics (NEO) Showcasing RaDaR ST Test for Oncology Drug Development
- Oct 27th, 2025 1:06 pm
NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect
- Oct 26th, 2025 9:15 pm
3 Healthcare Stocks Walking a Fine Line
- Oct 23rd, 2025 10:39 pm
3 Unprofitable Stocks with Open Questions
- Oct 19th, 2025 10:33 pm
Scroll